title: [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
abstract: alpha-2A-interferon is a useful and safe drug in Kaposi's sarcoma treatment although not free of serious side-effects when used at therapeutic dosages by which strict controls must be undertaken. When treatment has been interrupted, worsening and dissemination of the disease happened. No correlation has been found between immunologic parameters and the treatment used.
authors.affiliation: Departamento de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario San Carlos, Madrid.
authors.forename: E
authors.initials: E
authors.lastname: Lopez Bran
authors.forename: R
authors.initials: R
authors.lastname: Aguilar
authors.forename: J A
authors.initials: JA
authors.lastname: Marron
authors.forename: M A
authors.initials: MA
authors.lastname: Figueredo
authors.forename: J M
authors.initials: JM
authors.lastname: Garcia Ruiz
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000150:complications / Q000628:therapy*
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
vernacular_title: Tratamiento de cinco pacientes afectos de sarcoma de Kaposi y SIDA con interferon recombinante alfa-2A (roferon-A).